NCT03738111View on ClinicalTrials.gov

Study of TG02 Citrate in Patients With Advanced Hepatocellular Carcinoma

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 31, 2018

Primary Completion Date

August 31, 2021

Study Completion Date

December 31, 2021

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

TG02 Citrate

TG02 citrate capsules

Sponsors
All Listed Sponsors
collaborator

China Oncology Focus Limited

OTHER

lead

Lee's Pharmaceutical Limited

INDUSTRY